Provider Reviews

Start Willow vs Hers: Compounded Semaglutide vs FDA-Approved Wegovy

Start Willow logo

Start Willow vs Hers quickly compared: Start Willow provides compounded semaglutide from $249 per month with no insurance or membership and a 3 day delivery guarantee, while Hers offers FDA-approved Wegovy and other brand-name GLP-1s from $149 per month but requires an active membership for medication access. Early verdict: choose Start Willow if you need a direct-pay, no-insurance route and fast shipping; choose Hers if you want an FDA-approved brand-name option and a personalized care team.

Explore Start Willow pricing and shipping

How they differ: formulation, approval, and pricing

Start Willow and Hers diverge in three key areas: medication type and regulatory status, cost and membership structure, and clinical support plus delivery commitments. These differences drive who each provider is best for.

Medication type and regulatory status

Start Willow delivers once-weekly compounded semaglutide that is a customized treatment option created for Willow patients. Compounded semaglutide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality. It is prepared by state-licensed compounding pharmacies operating under state board of pharmacy oversight and USP compounding standards. Hers offers FDA-approved Wegovy, a brand-name semaglutide product, and emphasizes that it is not a compounded medication. Hers also lists other FDA-approved options such as Zepbound and notes Ozempic is FDA-approved for type 2 diabetes and may be prescribed off-label at a clinician’s discretion.

Cost, membership, and access

Start Willow operates on a direct-pay model: first month priced at $249 and ongoing at $299 per month, with no membership fees and no insurance required. This model is positioned for patients frustrated by insurance pre-authorization. Hers lists medication “from $149/mo” for a Wegovy pill and from $199/mo for injectables, but medication requires an active Hers Weight Loss Membership. The membership is $39 for the first month and auto-renews at $149/month thereafter, and medication is not available without an active membership. Hers cautions total cost, eligibility, renewal terms and state availability should be confirmed before enrollment.

Start Willow no-insurance ordering

Clinical support, personalization, and shipping

Hers highlights a personalized care team with ongoing dose check-ins and emphasizes doctor-trusted GLP-1s and brand-name medication with no price markups. Start Willow describes prescribing compounded semaglutide as part of a personalized treatment plan in collaboration with a Willow doctor and offers written and video injection instructions and support from the Willow Care Team. For delivery, Start Willow guarantees shipping in 3 days or less and offers same-day prescriptions and free 2 day shipping when in stock. Hers notes availability is not uniform in all 50 states and that prescriptions are subject to clinician determination.

Comparison table: Start Willow vs Hers

Criteria Start Willow Hers
Medication type Compounded semaglutide (customized) FDA-approved Wegovy and other brand-name GLP-1s
Regulatory status Compounded medications not FDA-approved FDA-approved products (Wegovy, Zepbound noted)
Starting price From $249 per month From $149 per month for Wegovy pill; injectables from $199
Membership required No membership fees; direct-pay Active membership required for medication access
Shipping/Delivery Guaranteed in 3 days or less; free 2 day shipping in stock Noted availability varies by state; shipping details conditional on prescription
Clinical support Online clinician review; personalized treatment plan; Willow Care Team Personalized care team with ongoing dose check-ins

Safety and regulatory notes

Both provider descriptions preserve regulatory distinctions: Start Willow emphasizes compound status and that compounded semaglutide is not FDA-approved and not reviewed by the FDA, while Hers highlights FDA-approved brand-name products. Neither provider’s materials in the supplied evidence promise specific outcomes. Hers states some medications are available only to patients who meet clinical eligibility criteria determined by a licensed provider.

Practical differences that matter to patients

Fast direct access: Start Willow removes insurance and membership barriers and guarantees a rapid shipping window, which may appeal to people who want a direct-pay route and quick fulfillment. Branded FDA approval: Hers offers FDA-approved Wegovy and other brand-name GLP-1s and a structured membership with ongoing dose check-ins, which may appeal to people who prioritize FDA approval and a formal follow-up program. Cost structure: Hers shows lower listed starting medication prices but requires a membership that contributes to total cost. Start Willow lists a lower first month price and a higher ongoing rate and emphasizes no membership fees.

Order Start Willow compounded semaglutide

Bottom line: Start Willow vs Hers

Start Willow vs Hers comes down to a tradeoff between compounded, direct-pay semaglutide with fast shipping and no membership, and FDA-approved brand-name GLP-1s with a membership and a personalized dose check-in program. Start Willow is suited to patients who want no insurance, no membership fees, and a 3 day delivery commitment. Hers is suited to patients seeking FDA-approved Wegovy or other brand-name GLP-1s and a structured care team, provided they confirm membership requirements, total cost, eligibility, and state availability.

Choose Start Willow if…

you prioritize a direct-pay model with no insurance or membership requirements, want compounded semaglutide prescribed online, and value a 3 day delivery guarantee.

Choose Hers if…

you prefer FDA-approved brand-name Wegovy or other brand-name GLP-1 options, want an ongoing personalized care team with dose check-ins, and accept membership requirements for medication access.

Primary keyword: Start Willow vs Hers

Ready to Compare Telehealth Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

More comparisons

Start Willow logo
Provider ReviewsStart Willow vs Wellorithm: Price, Coverage, Delivery ComparedStart Willow offers compounded semaglutide from $249/month with delivery in 3 days or less; Wellorithm offers compounded semaglutide and tirzepatide with clinicians in all 50 states.September 22, 2026
Start Willow logo
Provider ReviewsStart Willow vs TMates: Semaglutide Cost, Access, and CareStart Willow starts at $249 first month ($299/mo ongoing) with 3-day delivery; TMates is $199/month flat with 24/7 U.S. doctor access. Both use compounded semaglutide.September 22, 2026
Start Willow logo
Provider ReviewsStart Willow vs Telos Rx: Price, Delivery, and CompoundingStart Willow: compounded semaglutide from $249/month, no insurance, 3-day delivery. Telos Rx: semaglutide as low as $99/month, tirzepatide as low as $139, clinician approval required.September 22, 2026
Sesame Care logo
Provider ReviewsSesame Care vs Hers: Clinician Choice vs Brand-Name WegovySesame Care is a telehealth marketplace with clinician choice, flexible appointments and pricing starting at $59/mo. Hers offers FDA-approved Wegovy from $149/mo and a required membership.September 17, 2026
Hers logo
Provider ReviewsRegenics vs Hers: Compounded GLP-1s vs FDA-Approved Wegovy® OptionsRegenics offers compounded semaglutide and tirzepatide starting at $139 and $189 first month; Hers offers FDA-approved Wegovy® from $149 with a required membership.September 16, 2026
Hers logo
Provider ReviewsPallas Health vs Hers: Compounded Plans vs Brand-Name Wegovy® OptionsPallas Health offers clinician-chosen brand or compounded GLP-1s with compounded semaglutide from $139 first month. Hers offers FDA-approved Wegovy® from $149/mo with membership.September 15, 2026

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.